SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Sempra (SRE) trades at a trailing P/E of 35.5, forward P/E of 18.8. Trailing earnings yield is 2.81%, forward earnings yield 5.31%. PEG 0.22 (Peter Lynch undervalued ≤1.0). Graham Number is $63.79.
Criteria proven by this page:
- VALUE (30/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
- Forward P/E 18.8 (down from trailing 35.5) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.22 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 2.81% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 5.31% as earnings recover.
- Analyst consensus target $100.29 (+4.3% upside) — modest upside expected.
Overall SharesGrow Score: 56/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
30/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SRE
Valuation Multiples
P/E (TTM)35.5
Forward P/E18.8
PEG Ratio0.22
Forward PEG0.22
P/B Ratio2.06
P/S Ratio4.75
EV/EBITDA16.7
Per Share Data
EPS (TTM)$2.81
Forward EPS (Est.)$5.11
Book Value / Share$64.30
Revenue / Share$21.05
FCF / Share$-9.26
Yields & Fair Value
Earnings Yield2.81%
Forward Earnings Yield5.31%
Dividend Yield2.59%
Graham Number$63.79
SharesGrow IV$86.42 (-10.1%)
Analyst Target$100.29 (+4.3%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
18.4 |
19.95 |
1.94 |
2.47 |
2.72% |
| 2017 |
104.7 |
-1.29 |
2.12 |
2.40 |
2.81% |
| 2018 |
27.6 |
0.12 |
1.69 |
2.88 |
3.33% |
| 2019 |
19.2 |
0.17 |
2.11 |
3.89 |
2.70% |
| 2020 |
9.4 |
0.13 |
1.59 |
3.27 |
3.59% |
| 2021 |
31.3 |
-0.45 |
1.59 |
3.16 |
3.47% |
| 2022 |
22.8 |
0.35 |
1.79 |
3.13 |
3.03% |
| 2023 |
15.3 |
0.34 |
1.64 |
2.98 |
3.24% |
| 2024 |
19.4 |
-2.54 |
1.78 |
4.29 |
2.78% |
| 2025 |
31.4 |
-0.82 |
1.82 |
4.20 |
2.85% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$2.73 |
$10.18B |
$1.37B |
13.5% |
| 2017 |
$0.51 |
$9.64B |
$257M |
2.7% |
| 2018 |
$1.71 |
$10.1B |
$1.05B |
10.4% |
| 2019 |
$3.65 |
$10.83B |
$2.2B |
20.3% |
| 2020 |
$6.44 |
$11.37B |
$3.93B |
34.6% |
| 2021 |
$2.01 |
$12.86B |
$1.32B |
10.2% |
| 2022 |
$3.31 |
$14.44B |
$2.14B |
14.8% |
| 2023 |
$4.79 |
$16.72B |
$3.08B |
18.4% |
| 2024 |
$4.42 |
$13.19B |
$2.86B |
21.7% |
| 2025 |
$2.75 |
$13.71B |
$1.84B |
13.4% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$5.12 |
$4.71 – $5.48 |
$14.26B |
$13.56B – $14.79B |
8 |
| 2027 |
$5.53 |
$5.20 – $5.80 |
$13.56B |
$12.33B – $14.74B |
8 |
| 2028 |
$5.99 |
$5.86 – $6.12 |
$13.98B |
$13.8B – $14.16B |
2 |
| 2029 |
$6.50 |
$5.76 – $7.26 |
$13.34B |
$12.17B – $14.53B |
1 |
| 2030 |
$7.13 |
$6.32 – $7.96 |
$13.53B |
$12.34B – $14.74B |
1 |
